Related Experiment Video
Updated: Aug 17, 2025
08:55
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
17.9K
Protocol for Clinical GLP-1 Receptor PET/CT Imaging with [68Ga]Ga-NODAGA-Exendin-4
1Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Methods in Molecular Biology (Clifton, N.J.)
|December 12, 2022
Summary
This study introduces [68Ga]Ga-NODAGA-exendin-4, a novel radiotracer for imaging glucagon-like peptide 1 receptors (GLP-1Rs). It shows promise for visualizing beta-cell mass and detecting conditions like insulinomas and congenital hyperinsulinism.
Area of Science:
- Nuclear Medicine
- Radiochemistry
- Endocrinology
Background:
- Glucagon-like peptide 1 receptors (GLP-1Rs) play a crucial role in glucose homeostasis and are implicated in various endocrine disorders.
- In vivo imaging of GLP-1Rs offers a non-invasive method for disease characterization and therapeutic monitoring.
- Current imaging techniques for GLP-1Rs have limitations in specificity or accessibility.
Purpose of the Study:
- To develop and characterize a novel radiotracer, [68Ga]Ga-NODAGA-exendin-4, for high-specificity in vivo imaging of GLP-1Rs.
- To evaluate the potential of [68Ga]Ga-NODAGA-exendin-4 positron emission tomography (PET)/computed tomography (CT) for visualizing beta-cell mass in diabetes mellitus research.
- To assess the utility of this radiotracer for detecting GLP-1R-overexpressing pathologies such as insulinomas and congenital hyperinsulinism.
Main Methods:
- Radiolabeling of the NODAGA-exendin-4 conjugate with Gallium-68 (68Ga) using a simple and fast procedure.
- Comprehensive quality control assessments of the radiotracer to ensure stability and purity.
- Implementation and description of the [68Ga]Ga-NODAGA-exendin-4 PET/CT imaging protocol.
Main Results:
- [68Ga]Ga-NODAGA-exendin-4 forms a stable complex with high specificity for GLP-1Rs.
- The radiotracer enables visualization of beta-cell mass, showing potential for diabetes mellitus research.
- Sensitive detection of insulinomas and potential for identifying focal lesions in congenital hyperinsulinism were demonstrated.
Conclusions:
- [68Ga]Ga-NODAGA-exendin-4 is a promising radiotracer for in vivo GLP-1R imaging.
- This imaging approach holds significant potential for advancing the understanding and diagnosis of diabetes mellitus and related endocrine disorders.
- The described PET/CT procedures facilitate the clinical translation of this novel imaging agent.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
217
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
217
01:29Positron Emission Tomography
4.4K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.4K